Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LESTAURTINIB Cause Febrile neutropenia? 23 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Febrile neutropenia have been filed in association with LESTAURTINIB. This represents 28.8% of all adverse event reports for LESTAURTINIB.

23
Reports of Febrile neutropenia with LESTAURTINIB
28.8%
of all LESTAURTINIB reports
0
Deaths
23
Hospitalizations

How Dangerous Is Febrile neutropenia From LESTAURTINIB?

Of the 23 reports, 23 (100.0%) required hospitalization, and 8 (34.8%) were considered life-threatening.

Is Febrile neutropenia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LESTAURTINIB. However, 23 reports have been filed with the FAERS database.

What Other Side Effects Does LESTAURTINIB Cause?

Hypertriglyceridaemia (13) Clostridium difficile colitis (10) Death (10) Diarrhoea (10) Enterococcal infection (9) Sepsis (9) Bronchiolitis (8) Candida infection (8) Hypertension (8) Klebsiella infection (8)

What Other Drugs Cause Febrile neutropenia?

CYCLOPHOSPHAMIDE (11,318) DOXORUBICIN (8,844) VINCRISTINE (8,676) RITUXIMAB (6,382) CYTARABINE (6,142) METHOTREXATE (6,091) ETOPOSIDE (5,966) CARBOPLATIN (4,888) DEXAMETHASONE (4,382) PREDNISONE (3,956)

Related Pages

LESTAURTINIB Full Profile All Febrile neutropenia Reports All Drugs Causing Febrile neutropenia LESTAURTINIB Demographics